Human prostatic cells in culture: Different testosterone metabolic profile in epithelial cells and fibroblasts from normal or hyperplastic prostates

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 2, 1996, Pages 235-242

  Berthaut, Isabelle ^a   Portois, Marie Claire ^a   Cussenot, Olivier ^b   Mowszowicz, Irène ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MALE; PROSTATE; PROSTATE HYPERTROPHY; STROMA CELL; TESTOSTERONE METABOLISM;

EID: 0030152015     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00019-2     Document Type: Article

References (33)

1. 1. Coffey D. S. and Isaacs J. T.: The control of prostate growth. Urology 17 suppl. (1981) 17-24.
2. 2. Cunha G. R., Chung L. W. K., Shannon J. M., Taguchi O. and Fujii H.: Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Rec. Progr. Horm. Res. 39 (1983) 559-598.
3. 3. Berry S. J., Coffey D. S., Walsh P. C. and Ewing L. L.: The development of benign prostatic hyperplasia with age. J. Urol. 132 (1984) 474-479.
4. 4. Jonler M., Riehmann M., Brinkmann R. and Bruskewitz R. C.: Benign prostatic hyperplasia. Endrocr. Metab. Clin. N. Am. 23 (1994) 795-807.
5. 5. Boring C. C., Squires T. S., Tong T. and Montgomery S.: Cancer statistics. CA: Cancer J. Clin. 44 (1994) 7-26.
6. 6. Imperato-McGinley J., Gautier T., Zirinsky K., Hom T., Palomo O., Stein E., Vaughan E. D., Markisz J. A., Ramirez de Arellano E. and Kazam E.: Prostate visualization studies in males homozygous and heterozygous for 5α-reductase deficiency. J. Clin. Endocr. Metab. 75 (1992) 1022-1026.
7. 7. Wilson J. D., Griffin J. E. and Russell D. W.: Steroid 5α-reductase 2 deficiency. Endocr. Rev. 14 (1993) 577-593.
8. 8. Bartsch W., Greeve J. and Voigt K. D.: 17β-hydroxysteroid dehydrogenase in the human prostate: properties and distribution between epithelium and stroma in benign hyperplastic tissue. J. Steroid Biochem. 28 (1987) 35-42.
9. 9. Mowszowicz I. and Bardin C. W.: In vitro androgen metabolism in mouse kidney: high 3 keto-reductase (3α-hydroxysteroid dehydrogenase) activity relative to 5α-reductase. Steroids 23 (1974) 793-807.
10. 10. Cussenot O., Berthon P., Berger R., Mowszowicz I., Faille A., Hojman F., Teillac P., Le Duc A. and Calvo F.: Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J. Urol. 143 (1991) 881-886.
11. 11. Mowszowicz I., Kirchhoffer M. O., Kuttenn F. and Mauvais-Jarvis P.: Testosterone 5α-reductase activity of skin fibroblasts: increase with serial subcultures. Molec. Cell. Endocr. 17 (1980) 41-50.
12. 12. Cussenot O., Berthon P., Cochand-Priollet B., Maitland N. J. and Le Duc A.: Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. Exp. Cell Res. 214 (1994) 83-92.
13. 13. Droz D., Rousseau-Merck M. F., Jaubert F., Dielbold N., Nezelof C., Adafer E. and Mouly H.: Cell differentiation in Wilm's tumor (nephroblastoma): an immunohistochemical study. Hum. Pathol. 21 (1990) 536-544.
14. 14. Lineweaver H. and Burk D.: The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56 (1934) 658-666.
15. 15. Burton K.: A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62 (1956) 315-323.
16. 16. Bruchovsky N., Rennie P. S., Batzold F. H., Goldenberg S. L., Fletcher T. and McLoughlin M. G.: Kinetic parameters of 5α-reductase activity in stroma and epithelium of normal, hyperplastic and carcinomatous human prostates. J. Clin. Endocr. Metab. 67 (1988) 806-816.
17. 17. Berthon P., Cussenot O., Hopwood L., Le Duc A. and Maitland N. J.: Functional expression of SV 40 in normal human prostatic epithelial and fibroblastic cells: differentiation pattern of non-tumorigenic cell lines. Int. J. Oncol. 6 (1995) 333-343.
18. 18. Fjösne H. E., Haug E. and Sunde A.: Androgen metabolism in the different lobes of the prostate gland of intact, gonadectomized or hypophysectomized rats with or without androgen substitution. Scand. J. Clin. Lab. Invest. 54 (1994) 83-93.
19. 19. Bruchovsky N. and Lieskovsky G.: Increased ratio of 5α-reductase: 3α(β)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate. J. Endocr. 80 (1979) 289-301.
20. 20. McNeal J. E.: Origin and evolution of benign prostatic enlargement. Invest. Urol. 15 (1978) 340-345.
21. 21. Azumi N. and Battifora H.: The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin and alcohol-fixed tumors. Am. J. Clin. Pathol. 88 (1987) 286-296.
22. 22. Andersson S., Berman D. M., Jenkins E. P. and Russell D. W.: Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 354 (1991) 159-161.
23. 23. Thigpen A. E., Cala K. M. and Russell D. W.: Characterization of Chinese hamster ovary cell lines expressing human steroid 5α-reductase isozymes. J. Biol. Chem. 268 (1993) 17404-17412.
24. 24. Cowan R. A., Cowan S. K., Grant J. K. and Elder H. Y.: Biochemical investigations of separated epithelium and stroma from benign hyperplastic prostatic tissue. J. Endocr. 74 (1977) 111-120.
25. 25. Wilkin R. P., Bruchovsky N., Shnitka T. K., Rennie P. S. and Comeau T. L.: Stromal 5α-reductase activity is elevated in benign prostatic hyperplasia. Acta Endocr. 94 (1980) 284-288.
26. 26. Habib F. K., Tesdale A. L., Chisholm G. D. and Busuttil A.: Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate. J. Endocr. 91 (1981) 23-32.
27. 27. Turin S., Hochstrate H., Grunwald I., Flüchter St-H. and Krieg M.: Effect of aging on kinetic parameters of 5α-reductase in epithelium and stroma of normal and hyperplastic human prostate. J. Clin. Endocr. Metab. 67 (1988) 979-985.
28. 28. Weisser H., Turin S., Debus M. and Krieg M.: 5α-reductase inhibition by finasteride (Proscar®) in epithelium and stroma of human benign prostatic hyperplasia. Steroids 59 (1994) 616-620.
29. 29. Hudson R. W.: Comparison of nuclear 5α-reductase activities in the stromal and epithelial fractions of human prostatic tissue. J. Steroid Biochem. 26 (1987) 349-353.
30. 30. Morfin R. F., Di Stephano S., Bercovici J. P. and Floch H. H.: Comparison of testosterone, 5α-dihydrotestosterone and 5α-androstane-3β,17β-diol metabolisms in human normal and hyperplastic prostates. J. Steroid Biochem. 9 (1978) 245-252.
31. 31. Tunn S., Shulze H. and Krieg M.: 17β-hydroxysteroid oxidoreductase in epithelium and stroma of human prostate. J. Steroid Biochem. Molec. Biol. 46 (1993) 91-101.
32. 32. Boudou P., Cussenot O., Soliman H., Villette J. M., Teillac P., Le Duc A. and Fiet J.: Distinct androgen 5α-reduction pathways in cultured and immortalized epithelial cells from normal human adult prostate. J. Urol. 152 (1994) 226-231.
33. 33. McConnell J. D., Wilson J. D., George F. W., Geller J., Pappas F. and Stoner E.: Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J. Clin. Endocr. Metab. 74 (1992) 505-508.